http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14784271

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 2654
issn 1021-335X
1791-2431
issueIdentifier 5
pageRange 2648-2654
publicationName Oncology Reports
startingPage 2648
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bedb77db2f5a5d1100716ff3b6a8d6b3
bibliographicCitation Liang YX, Mo RJ, He HC, Chen JH, Zou J, Han ZD, Lu JM, Cai C, Zeng YR, Zhong WD, Wu CL. Aberrant hypomethylation-mediated CD147 overexpression promotes aggressive tumor progression in human prostate cancer. Oncol Rep. 2015 May;33(5):2648–54. PMID: 25813864; PMCID: PMC6918814.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4ea404453a15d50a72202dcd34f1517
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95fe0abd0ab2497bc74a864ff70cea79
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc8bb51457675f0b61121449e63eaacf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f538413d7d1bced599dbc0fdd0a6a1c0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0888bf87b7ebdd1bcd7a38831dc9019f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42b55fb1b4ab446861e3f1319366244d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cece6823c9eb99f46e8cb2d252b4f571
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0169dcfc1ab0e11e9a125bf1a9008ac
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3cf479d9e0602ec18e2b8bb6da63e92
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0f0270948b98e78672e82a0268fbb9c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b7a4c5dc62d08f4d772f05ddffca9f7
date 2015-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/25813864
https://doi.org/10.3892/or.2015.3870
https://pubmed.ncbi.nlm.nih.gov/PMC6918814
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20608
https://portal.issn.org/resource/ISSN/1021-335X
https://portal.issn.org/resource/ISSN/1791-2431
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Aberrant hypomethylation-mediated CD147 overexpression promotes aggressive tumor progression in human prostate cancer
discusses http://id.nlm.nih.gov/mesh/M0185536
http://id.nlm.nih.gov/mesh/M0328128
http://id.nlm.nih.gov/mesh/M0019167
http://id.nlm.nih.gov/mesh/M0177703
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D011471Q000235
http://id.nlm.nih.gov/mesh/D015972Q000235
http://id.nlm.nih.gov/mesh/D019175Q000235
http://id.nlm.nih.gov/mesh/D051926Q000235
hasSubjectTerm http://id.nlm.nih.gov/mesh/D011401Q000235
http://id.nlm.nih.gov/mesh/D001483
http://id.nlm.nih.gov/mesh/D063646Q000235
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D011467Q000473
http://id.nlm.nih.gov/mesh/D011471Q000473
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008969
http://id.nlm.nih.gov/mesh/D020778Q000235
http://id.nlm.nih.gov/mesh/D063646Q000473
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D018450
http://id.nlm.nih.gov/mesh/D012333Q000235
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6be0c5d46f46c0e756100c24a60c0490
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID451668
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID682

Total number of triples: 60.